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Abstract
Aim: The aim was to evaluate and compare the clinico-physiological, hemodynamic and hematobiochemical effects in 
response to different total intravenous anaesthesia techniques using xylazine or dexmedetomidine with propofol in canine 
patients.
Materials and Methods: Under a prospective randomized blinded clinical study, 12 apparently healthy adult dogs 
(14.27±3.2 kg) divided into two groups (n=6). Animals were administered with xylazine (0.5 mg/kg body weight IV) 
in X group or, dexmedetomidine (10 μg/kg body weight IV) in D group and propofol (as IV bolus till the induction and 
continuous IV infusion for maintenance). Clinical reflexes, physiological, hemodynamic parameters, were recorded at 
5-min intervals. Blood was collected at zero, 30 and 60 min after initial injection for hematobiochemical evaluation. 
Statistical analysis was performed using analysis of variance, Duncan’s multiple range tests, paired - t-test and 
Kruskal–Wallis one-way test.
Results: Animals showed quicker attenuation of all clinical reflexes in group D. Induction doses of propofol were 3.17±0.21 
and 2.72±0.15 mg/kg and rate of infusion of propofol for maintenance of anaesthesia were 0.33±0.02 mg/kg/min and 
0.35±0.02 mg/kg/min respectively in group X and D. Recovery was quicker in group D. There were no significant statistical 
differences in physiological, hemodynamic and hematobiochemical parameters in both the groups. There were no adverse 
effects after recovery.
Conclusion: Both anesthetic protocols provided satisfactory immobilization, but dexmedetomidine-propofol combination 
may be preferred owing to slightly better degree of basal anaesthesia, lesser doses of propofol required for induction and 
maintenance of anaesthesia along with a lesser degree of respiratory depression. However, there was no clear preference for 
either of the protocol, and both appear suitable for canines.
Keywords: alpha2 adrenoreceptor agonist, canine surgery, dexmedetomidine, propofol, total intravenous anaesthesia, xylazine.
Introduction
Surgical management of canine patients, being 
a painful and inflammatory response, always neces-
sitate an ideal anesthetic, which produces sleep, 
amnesia, analgesia and muscle relaxation to facilitate 
well-being of the surgical patient [1]. Inability of a 
sole agent to achieve aforementioned characteristics, 
a combination of drugs is used, which is referred to 
as balanced anaesthesia [2]. Balanced anesthetic tech-
niques using intravenous (IV) anesthetics produce 
rapid onset, redistribution and clearance along with 
nonappearance of disadvantages of inhalant anesthet-
ics like use of a cumbersome and costly anesthetic 
machines [3], exposure of operating-room personnel 
to the pollution [4], explains the skewed interest of 
veterinarians towards the use of total intravenous 
anaesthesia (TIVA) [5].
Propofol infusion as 1% emulsion may be used 
as part of TIVA regime and has established itself as a 
qualified maintenance anesthetic with a good quality 
recovery [6]. Propofol as sole agent for TIVA is gen-
erally unsatisfactory, since its poor analgesic property. 
Consequently, it is necessary to supplement propofol 
with an analgesic and muscle relaxant [7].
Xylazine and dexmedetomidine, being two 
α2-adrenergic receptor agonists, mediate sedative, 
anxiolytic and analgesic effects [8]. The α2/α1-receptor 
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binding selectivity indicates that the medetomidine 
is more selective and specific α2-adrenergic recep-
tor agonist than xylazine [9]. Dexmedetomidine is a 
potent and selective α2-adrenergic agonist, the active 
enantiomer of medetomidine [10] and clinical effects 
are presumed to be comparable with those of race-
mic medetomidine [11]. However, studies showing 
the comparative anesthetic evaluation of TIVA com-
prising combination of propofol premedicated with 
dexmedetomidine and atropine with combination of 
propofol premedicated with xylazine and atropine in 
surgical management of canine patients are lacking.
In the present study, we evaluated and compared 
the clinico-physiological, hemodynamic and hema-
tobiochemical effects in response to different TIVA 
techniques using atropine, xylazine/dexmedetomi-
dine, propofol in canine patients.
Materials and Methods
Animals
Twelve nondescript adult canines of either sex 
weighing 12-20 kg were used in this prospective clini-
cal study and divided randomly into two groups X and 
D consisting of six animals each based on the anes-
thetic regimen given. The animals were apparently 
healthy, vaccinated and dewormed with free access to 
feed and water but remained off feed for 16 h, and 
water was withheld for 8-12 h prior to the start of the 
surgery.
Anesthetic protocols
Anaesthesia was achieved by administration of 
atropine (0.045 mg/kg body weight intramuscular), 
xylazine (0.5 mg/kg body weight IV) and propofol 
(as IV till the induction and continuous IV infusion 
for maintenance) sequentially at 5 min intervals. 
Anesthetic protocol used in group D is similar to that 
of group X but instead of xylazine, dexmedetomidine 
was administered intravenously at the rate of 10 μg/kg 
body weight.
Evaluation of clinico-physiological parameters
The baseline values (time=0) for physiological 
and clinical parameters were made before injection 
of the drug. The examiner for the subjective deter-
mination of scores for various reflexes and jaw tone 
was not blinded, but was the same person during each 
trial throughout the period of study. Palpebral, cor-
neal and pedal reflexes were recorded at 0 min and 
then at 5, 10, 15, 30, 45, 60, 75, 90, 105 and 120 min 
after injection of drugs or till the end of the surgical 
procedure and graded in a scale of 1-4, where 1 rep-
resents no change in reflex, 2 represents moderate 
reflex, 3 represents sluggish reflex and 4 represents 
absence of reflex. Similarly, tonicity of jaw muscle 
was recorded as above and graded in a scale of 1-4, 
where 1 represents normal tone, 2 represents moderate 
tone, 3 represents sluggish tone, and 4 represents the 
absence of jaw tone. Physiological parameters such as 
heart rate (HR- beats/min), pulse rate (PR- beats/min), 
respiratory rate (RR- breaths/min), rectal temperature 
(RT- °C) and hemodynamic parameters like systolic 
blood pressure (SBP- mm of Hg), diastolic blood 
pressure (DBP- mm of Hg), mean arterial pressure 
(MAP- mm of Hg) and haemoglobin oxygen sat-
uration (SpO2- %) were also recorded at same time 
intervals. Duration of maintenance of anaesthesia 
(start of propofol administration till the cessation), 
total duration of anaesthesia (induction of anaesthe-
sia till appearance of pedal reflex) and recovery time 
(of propofol administration to reappearance of pedal 
reflex) were calculated in minutes. Total dose of 
propofol for induction (mg/kg) and rate of infusion of 
propofol (mg/kg body weight/min) were also calcu-
lated in each group.
Evaluation of hematobiochemical parameters
Blood samples were also collected at time zero 
before drug administration and at 30 and 60 min after 
induction of anaesthesia for the estimation of total leu-
kocyte count (TLC) (×109/L), differential leukocyte 
count (DC) (%), packed cell volume (PCV) (L/L), 
haemoglobin  (g/L), blood glucose (mg/dL), plasma 
urea nitrogen (mg/dL), creatinine (mg/dL) and corti-
sol (nmol/L).
Statistical analysis
Analysis of variance and Duncan’s multiple 
range tests were used to compare the means at differ-
ent intervals among different groups. Paired – t-test 
was used to compare the mean values at different lev-
els with their respective base value in each group [12]. 
For non-parametric observations Kruskal–Wallis one-
way test was used to compare the mean between the 
groups at corresponding intervals [13].
Results
Clinical parameters
The body weight of animals was 14.27±3.2 kg. 
The pedal reflex scores increased non-significantly 
(p>0.05) after administration of xylazine/dexmede-
tomidine and started to abolish at 10 min, followed 
by complete abolishment from 15 to 75 min and 
then remained sluggish until the end (Figure-1). The 
Figure-1: Mean±Standard error scores of pedal reflex in 
animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
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palpebral reflex scores increased non-significantly 
(p>0.05) from 10 min up to 60 min in group X and 
75 min in group D, which was followed by non-sig-
nificant (p>0.05) decrease in the palpebral reflex 
score (Figure-2). The corneal reflex followed the 
similar trend like other clinical reflexes (Figure-3). 
As shown in the Figure-4 jaw tone was present in the 
animals of group X and remained sluggish in group D 
after the administration of respective preanesthetics 
at 10 min followed by complete abolishment after 
propofol administration. Comparison among the dif-
ferent groups revealed that there was no significant 
(p>0.05) difference between groups during the evalu-
ation of clinical reflexes and jaw tone score at various 
intervals.
Dose rates of propofol during induction and 
maintenance
The induction dose of propofol (mg/kg) in 
groups X and D was 3.17±0.21 and 2.72±0.15 mg/kg 
respectively which were not significantly (p>0.05) 
different to each other. The rate of infusion of propo-
fol for maintenance of anaesthesia in groups X and 
D was 0.33±0.02 and 0.35±0.02 mg/kg/min respec-
tively which were not significantly (p>0.05) differ-
ent to each other. The duration of maintenance of 
anaesthesia in groups X and D was 57.17±3.78 and 
35.83±1.82 min respectively which were significantly 
(p<0.01) different to each other. The total duration of 
anaesthesia in groups X and D was 72.5±3.35 min 
and 54.33±2.99 min respectively which were signifi-
cantly (p<0.01) different to each other. The recov-
ery time in group X and D was 11.17±1.14 min and 
13.67±1.02 min respectively with no significant 
(p>0.05) difference among different groups.
Physiological parameters
As shown in Figure-5 the HR increased non-sig-
nificantly (p>0.05) in group X at 5 min after atropine 
administration followed by a significant decrease 
(p<0.01) from 10 min up to 15 min. It increased 
thereafter and maintained around the base line till 
the end of the observation period. Like group X, the 
HR increased non-significantly (p>0.05) in group D 
at five but followed an opposite trend to group X 
subsequently. Comparison between both groups 
suggested a significant difference (p<0.05) among 
HR at 10 min and 15 min time intervals. In group X 
there was a non-significant (p>0.05) decrease in the 
RR at 5 min. However, the decrease in RR was sig-
nificant (p<0.01) from 10 min until the end of the 
observation period, where it remained lower than 
Figure-2: Mean±Standard error scores of palpebral reflex 
in animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
Figure-3: Mean±Standard error scores of corneal reflex 
in animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
Figure-4: Mean±Standard error scores of jaw tone in 
animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
Figure-5: Mean±Standard error values of heart rate in 
animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
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the base value as shown in Figure-6. In group D, RR 
decreased non-significantly (p>0.05) from 5 min but 
the decrease was significant (p<0.01) at 10 min and 
values remained significantly (p<0.01) lower than the 
base value. Comparison between both groups sug-
gested a significant difference (p<0.05) among RR 
at 5 min and 15 min time intervals. In group X there 
was a slight and non-significant (p>0.05) decrease in 
RT at 10 min, which decreased significantly (p<0.05) 
at 15 min and it remained significantly (p<0.01) 
less from 30 min until the end of observation period 
shown in Figure-7. In group D, there was a slight 
and non-significant (p>0.05) increase in RT at 5 min, 
10 min, which is followed by a significant (p<0.01) 
decline in RT from 15 min onwards. Comparison 
between both groups suggests that there was no sig-
nificant difference in the RT values among different 
groups.
Hemodynamic parameters
As shown in Figure-8 in group X there was a 
significant (p<0.05) decrease in SBP at 5 min fol-
lowed by a non-significant (p>0.05) increase in SBP 
from 10 to 15 min time interval. After this there was 
a significant (p<0.05) decline in SBP at 30 min and 
60 min time intervals and highly significant (p<0.01) 
decline in SBP at 45 min, 75 min and 90 min time 
intervals. In group D there was a non-significant 
(p>0.05) decrease in SBP at 5 min followed by a 
non-significant (p>0.05) increase in SBP at 10 min 
time interval. After this, there was a non-significant 
(p>0.05) decline in SBP from 30 to 75 min time 
interval followed by a non-significant (p>0.05) rise 
in SBP at 90 min time interval. Comparison between 
both groups suggested that there was a significant 
difference (p<0.05) among SBP at 30 min, 45 min 
and 90 min time intervals. As shown in Figures-9 and 
10, values of DBP and MAP showed almost similar 
trends with respect to values of SBP of correspond-
ing groups and comparison between both groups 
suggests that there was a significant difference 
(p<0.05) in the DBP and MAP values among differ-
ent groups. As shown in Figure-11 in group X the 
SpO2 remained almost similar or slightly increased 
non-significantly (p>0.05) at different intervals 
but significantly (p<0.01) decreased at 5 min and 
10 min time interval when compared to the base 
value. In group D the SpO2 remained almost simi-
lar or slightly increased non-significantly (p>0.05) 
at different intervals, but significantly (p<0.01) 
decreased at 5 min time interval as compared to 
the base value. Comparison between both groups 
Figure-6: Mean±Standard error values of respiratory rate 
in animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
Figure-7: Mean±Standard error values of rectal 
temperature in animals of different groups. *Significantly 
different from the base value (p<0.05). **Significantly 
different from the base value (p<0.01).
Figure-8: Mean±Standard error values of systolic blood 
pressure in animals of different groups. *Significantly 
different from the base value (p<0.05). **Significantly 
different from the base value (p<0.01).
Figure-9: Mean±Standard error of diastolic blood pressure 
in animals of different groups. *Significantly different from 
the base value (p<0.05). **Significantly different from the 
base value (p<0.01).
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suggests that there was no significant difference in 
the SpO2 values among different groups.
Hematological parameters
Values of Hb and PCV showed a non-significant 
increase at 30 min in group X followed by a non-sig-
nificant (p>0.05) decrease at 60 min, but remained 
below the base value as shown in Table-1. A significant 
(p<0.05) decrease in Hb and non-significant (p>0.05) 
decrease in PCV from the base value were recorded 
in group D at 30 min, followed by a non-significant 
(p>0.05) rise at 60 min. In group X, TLC showed a 
non-significant (p>0.05) decrease at 30 min, followed 
by a significant (p<0.05) decrease at 60 min and in 
group D, TLC showed a non-significant (p>0.05) 
increase at 30 min followed by non-significant (p>0.05) 
decrease at 60 min. Neutrophil count showed non-sig-
nificant (p>0.05) increase in both the groups whereas 
lymphocyte count showed a significant (p<0.05) 
decrease in group X and non-significant (p>0.05) 
decrease in group D. Eosinophil count showed a 
non-significant (p>0.05) increase in group X whereas it 
showed a non-significant (p>0.05) decrease in group D. 
Comparison among different groups revealed no signif-
icant (p>0.05) difference in the hematological values 
between the groups as shown in Table-1.
Biochemical parameters
Values of glucose showed a non-significant 
(p>0.05) increase in group X whereas its value showed 
non- a significant decline in group D that remained 
below the base value. Comparison among different 
groups revealed that at 60 min the value of glucose 
in group X was significantly (p<0.05) higher than in 
group D. Values of urea nitrogen and creatinine showed 
a similar pattern in both the groups where there was a 
non-significant (p>0.05) decrease at 30 min followed 
by a non-significant (p>0.05) increase at 60 min. But 
the comparison among different groups revealed that 
at 60 min the value of creatinine in group X was sig-
nificantly (p<0.05) higher than in group D. Values of 
cortisol showed non-significant (p>0.05) increase in 
both the groups but group X showed a significantly 
(p<0.05) lower value of plasma cortisol than group D 
at 30 min.
Discussion
Clinical parameters
Clinical observations like pedal, palpebral and 
corneal reflexes were satisfactory indicators for 
ascertaining the onset and depth of analgesia and 
anaesthesia. Scores of all the reflexes increased after 
the administration of xylazine/dexmedetomidine and 
propofol in both the groups. Xylazine group caused 
a moderate decrease in all the reflexes whereas dex-
medetomidine group scored higher with moderate 
loss of all the reflexes due to high potency owing 
to the specificity of medetomidine for α2-adreno-
receptors than xylazine [9]. All the reflexes were 
abolished completely after induction of anaesthesia 
with propofol in the both the groups suggesting that 
the surgical stage of anaesthesia has reached [14]. 
The cumulative effect of xylazine/dexmedetomidine 
and general anesthetic propofol might have caused 
attenuation of all the reflexes. Resistance to open the 
mouth fully is lost in moderate anaesthesia, hence 
jaw tone is considered to be a useful indicator of 
anaesthesia [15,16]. Jaw tone became sluggish after 
the administration of xylazine/dexmedetomidine in 
both the groups due to inhibition of α2 adrenocep-
tors in the interneuron level of spinal cord [17]. But 
the jaw tone score was more in the dexmedetomi-
dine group than the xylazine group due to the higher 
potency of dexmedetomidine [9].
Dose rates of propofol during induction and 
maintenance
α2-adrenergic agonists have marked anes-
thetic sparing effects both for the induction and 
maintenance of anaesthesia. Premedication with 
dexmedetomidine and xylazine was found to 
decrease anesthetic requirements during anaes-
thesia with propofol [14,18]. Induction doses of 
propofol in the groups X and D were 3.17±0.21 and 
2.72±0.15 mg/kg respectively in accordance with 
the reported induction dose of 2.2-3.3 mg/kg [18]. 
Figure-10: Mean±Standard error values of mean arterial 
pressure in animals of different groups. *Significantly 
different from the base value (p<0.05). **Significantly 
different from the base value (p<0.01).
Figure-11: Mean±Standard error values of oxygen 
saturation of haemoglobin in animals of different groups. 
*Significantly different from the base value (p<0.05). 
**Significantly different from the base value (p<0.01).
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However, dexmedetomidine group had relatively 
less dose of propofol for induction than xylazine 
group as former was more potent than latter at equal 
doses. Rate of infusion of propofol for maintenance 
of anaesthesia in group X was 0.33±0.02 mg/kg/min 
and was 0.35±0.02 mg/kg/min in group D which 
was in accordance earlier studies where rate of 
infusion of propofol by CII was in the range of 
0.15-0.5 mg/kg/min in dogs [15,19]. The propofol 
requirement for induction and maintenance of anaes-
thesia was found to be greatly reduced by premedi-
cation with α2 agonists [14]. The duration of mainte-
nance of anaesthesia for group X was 57.17±3.78 min 
and in group D, it was 35.83±1.82 min which was in 
the range of 38-62 min duration of maintenance of 
anaesthesia in canines [14]. Although total duration 
of anaesthesia dependent on the nature of surgical 
procedure, in groups X and D, it was 72.5±3.35 and 
54.33±2.99 min respectively. The duration was the 
shorter in D as compared to group X and falling in 
the range of 66-79 min which has been reported by 
Surbhi (2010) [14]. Recovery from anaesthesia in all 
the groups was smooth and uneventful and its dura-
tion was higher in dexmedetomidine group which in 
accordance to an earlier study in humans where a low 
dose of dexmedetomidine was found to reduce the 
propofol infusion dose but did not affect the phar-
macokinetics of propofol or recovery time after infu-
sion [20]. Rapid and smooth recovery recorded in the 
present study was in accordance with that reported in 
the earlier studies [21] in dogs. It is evident from the 
present study that propofol is an ideal general anes-
thetic for longer duration of surgeries requiring an 
hour or more, without significantly affecting the vital 
body functions.
Physiological and hemodynamic parameters
HR increased after the administration of atro-
pine in all the groups which might be due to the 
antagonistic activity of atropine with acetylcho-
line [22]. α2 agonists affected cardiovascular func-
tion [23] with increased vagal tone and decreased 
sympathetic activity to effect bradycardia [24]. 
However, in the present study, an increase in HR 
was observed after the administration of xylazine/
dexmedetomidine which is in accordance with the 
earlier studies in which preemptive administration of 
atropine was capable of reversing α2 agonist-induced 
bradyarrhythmias in dogs [25]. After the adminis-
tration of propofol, HR increased similar to earlier 
findings reported in dogs [21,26]. This may be due 
to positive chronotropic effect of propofol [14] or, 
increased myocardial blood flow [27] or, combina-
tion of both. RR was not much affected by the admin-
istration of atropine. However, depression in RR was 
observed after the administration of preanesthetics 
due to direct depression of the respiratory centers in 
the brain [28]. Induction of anaesthesia with propofol 
also caused a decrease in RR that was in accordance 
to earlier studies in dogs [21]. Respiratory depres-
sion and apnea, being the most commonly reported 
adverse effect of propofol anaesthesia, was propor-
tional to rate of infusion of propofol [29,30]. In the 
present study, the rate of infusion of propofol was the 
most vital parameter to be controlled based on the RR 
and SpO2. RT decreased in all the groups after the 
administration of preanesthetics that was due to CNS 
depression in combination with a reduction in muscu-
lar activity and basal metabolic rate [31]. The induc-
tion of anaesthesia with propofol caused a further 
significant decrease in the RT but remained within an 
Table-1: Effects of intravenous administration of xylazine/dexmedetomidine along with propofol on haematological and 
biochemical parameters in canine patients (mean±SE).
Parameters Group# Baseline 30 min 60 min
Hb (g/L) X 10.62±0.31 11.00±0.42 9.90±0.38
D 12.38±0.42 10.67±038* 12.15±0.42
PCV (L/L) X 0.39±0.01 0.41±0.02 0.39±0.02
D 0.39±0.01 0.35±0.02 0.38±0.03
Neutrophil count (%) X 64.17±3.66 68.67±4.00 69.33±3.27
D 69.83±3.24 68.17±2.63 70.17±2.85
Lymphocyte count (%) X 31.17±2.12 23.33±2.20* 27.67±3.56
D 30.17±0.79 28.50±1.06 23.33±2.44*
Eosinophil count (%) X 3.67±0.92 4.50±1.02 5.33±1.05
D 5.00±1.71 5.33±1.26 4.67±1.20
TLC (%) X 9.33±0.76 7.67±0.67 6.33±0.61*
D 12.07±1.70 12.77±1.48 8.68±0.78
Glucose (mg/dL) X 73.16±3.57 79.33±3.49 82.66±4.84
D 76.66±6.31 86.83±5.48 68.83±2.45
Plasma urea nitrogen (mg/dL) X 14.66±1.40 11±1.84* 15±1.87
D 13.33±2.06 13±2.50 17.66±0.88
Creatinine (mg/dL) X 1.78±0.35 1.033±0.28 1.75±0.27
D 1.71±0.36 1.07±0.27 2.01±0.22
Cortisol (nmol/L) X 46.76±3.83 73.43±4.45 98.56±8.29
D 71±5.81 110±6.59 110.33±9.58 
#X=Xylazine and propofol administered group, D=dexmedetomidine and propofol administered group. *Significantly 
different from the base value (p<0.05), **Significantly different from the base value (p<0.01). Hb=Haemoglobin, 
PCV=Packed cell volume, TLC=Total leucocyte count, IV=Intravenous
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acceptable range, which was in accordance to earlier 
studies [21,26,30]. Blood pressure (BP) increased 
after the administration of atropine, and there was 
further significant increase in BP after the admin-
istration of xylazine or dexmedetomidine, which 
was due to the stimulation of peripheral α2B agonist 
receptors mediated transient initial hypertension of 
variable duration [32]. The transient hypertension 
induces a reflex baroreceptor mediated physiologic 
bradycardia [33]. In the present study, the initial 
hypertension and subsequent decrease in BP might 
have occurred by a similar mechanism. Propofol has 
been reported to decrease systemic arterial BP due to 
peripheral vasodilation [34], direct negative inotro-
pic action and direct decrease of arterial and venous 
vascular tone [14]. The findings of the present study 
suggest that administration of propofol helps to alle-
viate dexmedetomidine induced vasoconstriction, 
which is in accordance with the previous study [35]. 
Initial decrease in SpO2 in animals of all the groups 
may be attributed to vasoconstriction [36] caused by 
xylazine/dexmedetomidine as reported by Kuusela 
et al. (2000) [37]. SpO2 decreased after the induction 
of anaesthesia with propofol in all the groups due to 
the respiratory depression causing a decrease in RR, 
which was in accordance to earlier studies [29,30,38].
Hematological parameters
Decrease in Hb and PCV values was attributed 
to pooling of circulating erythrocytes in the spleen or 
other reservoirs secondary to decreased sympathetic 
stimulation [14,28] or due to intercompartmental 
fluid shift in order to maintain normal cardiac out-
put [39] or due to hemodilution in response to fluid 
therapy [14,28]. The present finding is in accordance 
with the earlier studies in which a significant decrease 
in Hb and PCV was observed after the administra-
tion of α2 agonists in dogs. A similar decrease in the 
Hb level was also recorded in the propofol anaes-
thesia [40]. However, an increase in PCV was also 
reported in studies involving α2 agonists in goats, 
and this was explained by increased urine produc-
tion due to activation of capillary fluid shift mecha-
nism or by the release of the splenic red blood cells 
reservoir [28]. Differential leukocyte count showed 
a rise in neutrophil count and the lymphocyte count 
in each group varied conversely to the neutrophil 
count. There was no regular pattern of change in the 
eosinophil count. No significant change in monocyte 
and basophil count was noticed in any group at any 
interval. Increase in neutrophil count may be due to 
severe stress inflicted upon the animal during painful 
surgeries along with the anesthetic stress leading to 
stimulation of the adrenal cortex and subsequent pro-
duction of glucocorticoid that acts on the circulating 
neutrophils [41]. A similar mechanism might have 
involved in increasing the neutrophil count during the 
present study which was in accordance to an earlier 
study in dogs [42]. The decrease in TLC, observed in 
the present study, was consistent with the findings of 
earlier studies using propofol in dogs [40] and using 
α2 agonists in dogs [14,28] which might be due to the 
pooling of circulating blood cells in spleen or other 
reservoirs secondary to decreased sympathetic activ-
ity in dogs [41]. An increase in TLC has also been 
reported in dogs [42] which explain the rise in TLC 
in group D.
Biochemical parameters
Hyperglycemic effects of α2 agonists medeto-
midine [14] and dexmedetomidine [23] have been 
investigated in earlier studies which is due to sup-
pression of insulin release, stimulation of glucagon 
release, or both, in α and β cells of the pancreas, 
respectively [43]; also recorded with propofol anaes-
thesia in dogs [40]. Hyperglycemia observed in the 
present study may be due to the said mechanisms. 
The high rise of glucose during anaesthesia in the 
present study might also be attributed to decreased 
membrane transport of glucose, decreased glucose 
utilization, impaired insulin activity and increased 
blood concentration of adrenocortical hormones as 
reported in dogs [44]. Increase in BUN after the 
administration of propofol has been recorded [45] 
which may be due to reduced blood flow to kidneys 
leading to retention of nitrogenous substances in 
the blood. This explains the increase in plasma urea 
nitrogen values in the present study. However, in the 
present study, the decrease in PUN might be due to 
the continuous infusion of IV fluids thus maintain-
ing the normal kidney functions. However, all the 
observed values of PUN were within the normal 
physiological limits. The fluctuations in creatinine 
values were attributed to the inhibitory effect of 
drugs on the renal blood flow, increased creatinine 
production from muscle damage and amino acid deg-
radation [28,44]. However, in the present study, the 
creatinine level was within the normal physiological 
limits and the decrease may be due to continuous IV 
fluid infusion. Cortisol value indicates stress level of 
the animal. Various studies have shown that α2 ago-
nists reduce the preoperative levels of stress-related 
hormones and thus attenuate the stress response of 
surgery in dogs [46]. Clinical doses of IM racemic 
medetomidine had no influence on canine cortisol 
levels [47]. Even propofol infusion anaesthesia had 
no influence on plasma cortisol concentration at the 
end of anaesthesia and during recovery in dexme-
detomidine-premedicated dogs [48]. In the present 
study, cortisol values might have increased before 
anaesthesia as the animal was already under stress 
before surgery owing to the pain and unnatural envi-
ronment in the clinics. Then owing to the stress atten-
uation response of xylazine/dexmedetomidine, the 
cortisol levels might have reduced at 30 min interval. 
However, the cortisol levels ultimately increased due 
to the severe anesthetic and surgical stress in the ani-
mals. The overall observation on blood biochemical 
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parameters indicated that the anesthetic and surgical 
stress was responsible for the changes in their values, 
but the changes were transient in nature and not of 
any clinical significance.
Miscellaneous clinical observations
Among other observations Diuresis was 
observed in the animals of both xylazine and dex-
medetomidine groups attributed to α2 agonists medi-
ated inhibition of release of antidiuretic hormone in 
dogs [49] or osmotic diuretic effect of increased blood 
glucose by α2 agonists [50]. Muscle twitching fol-
lowing the administration of medetomidine has been 
described in dogs [51,52] which is also observed in 
the present study may be a hypersensitivity response 
to noise [51]. Nausea was observed in one animal of 
dexmedetomidine group and two animals of xylaizne 
group during anaesthesia. Since vomiting caused by 
α2 adrenoceptor agonist, xylazine, in cats was shown 
to follow the stimulation of receptors in the chemore-
ceptor trigger zone in the brain [53] dexmedetomidine 
could have a similar effect [23]. The same mechanism 
might have contributed to nausea in the present study.
Conclusion
The propofol requirement for induction and 
maintenance of anaesthesia was found to be greatly 
reduced by premedication with α2 agonists. The dura-
tion of maintenance of anaesthesia was the shorter 
in group D when compared to group X. Recovery 
time slightly higher in the dexmedetomidine group 
than the xylazine group. Although dexmedetomidine 
showed quicker attenuation of all clinical reflexes 
when compared to xylazine but auxiliary experiments 
would be needed to uphold the hypothesis that dex-
medetomidine also possessed a local analgesic action 
similar to that of xylazine. HR increased due to the 
combined action of preemptive vagolytic atropine 
and propofol administration. Administration of xyla-
zine or dexmedetomidine caused a decrease in RR 
and RT that was exacerbated after subsequent propo-
fol administration, but remained within normal phys-
iological limits. The hematological and biochemical 
changes recorded by these drugs were evanescent in 
nature and returned to basal values as the effects of 
these drugs weaned off. Both xylazine and dexmede-
tomidine caused nausea and renal diuresis. Although 
there was no response to external stimuli, but most 
had involuntary ear twitches. On the basis of find-
ings in the present study, dexmedetomidine provided 
slightly better degree of basal anaesthesia than xyla-
zine in canine patients. Atropine-xylazine-propofol 
and atropine-dexmedetomidine-propofol can be 
employed safely for anesthetic management of canine 
patients without significantly affecting the vital body 
functions. However, latter may be preferred owing to 
lesser doses of propofol required for induction and 
maintenance of anaesthesia along with a lesser degree 
of respiratory depression.
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